Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 5380638, 9 pages
https://doi.org/10.1155/2017/5380638
Clinical Study

A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease

1Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevaal, Oslo, Norway
2Center for Heart Failure Research, Oslo University Hospital Ullevaal, Oslo, Norway
3Faculty of Medicine, University of Oslo, Oslo, Norway
43rd Medical Department for Cardiology, Wilhelminenspital, Vienna, Austria
5The Blood Cell Research Group, Department of Medical Biochemistry, Oslo University Hospital Ullevaal, Oslo, Norway

Correspondence should be addressed to Ida Unhammer Njerve; on.oiu.nisidem@evrejn.u.i

Received 24 November 2016; Revised 31 March 2017; Accepted 6 April 2017; Published 17 May 2017

Academic Editor: Julio Galvez

Copyright © 2017 Ida Unhammer Njerve et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ida Unhammer Njerve, Sissel Åkra, Thomas W. Weiss, et al., “A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease,” Mediators of Inflammation, vol. 2017, Article ID 5380638, 9 pages, 2017. https://doi.org/10.1155/2017/5380638.